Correlation Between Universe Pharmaceuticals and Sonoma Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Universe Pharmaceuticals and Sonoma Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Universe Pharmaceuticals and Sonoma Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Universe Pharmaceuticals and Sonoma Pharmaceuticals, you can compare the effects of market volatilities on Universe Pharmaceuticals and Sonoma Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Universe Pharmaceuticals with a short position of Sonoma Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Universe Pharmaceuticals and Sonoma Pharmaceuticals.

Diversification Opportunities for Universe Pharmaceuticals and Sonoma Pharmaceuticals

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between Universe and Sonoma is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Universe Pharmaceuticals and Sonoma Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonoma Pharmaceuticals and Universe Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Universe Pharmaceuticals are associated (or correlated) with Sonoma Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonoma Pharmaceuticals has no effect on the direction of Universe Pharmaceuticals i.e., Universe Pharmaceuticals and Sonoma Pharmaceuticals go up and down completely randomly.

Pair Corralation between Universe Pharmaceuticals and Sonoma Pharmaceuticals

Considering the 90-day investment horizon Universe Pharmaceuticals is expected to under-perform the Sonoma Pharmaceuticals. In addition to that, Universe Pharmaceuticals is 1.77 times more volatile than Sonoma Pharmaceuticals. It trades about -0.29 of its total potential returns per unit of risk. Sonoma Pharmaceuticals is currently generating about 0.03 per unit of volatility. If you would invest  281.00  in Sonoma Pharmaceuticals on September 2, 2024 and sell it today you would lose (2.00) from holding Sonoma Pharmaceuticals or give up 0.71% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Universe Pharmaceuticals  vs.  Sonoma Pharmaceuticals

 Performance 
       Timeline  
Universe Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Universe Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Sonoma Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Sonoma Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent basic indicators, Sonoma Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

Universe Pharmaceuticals and Sonoma Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Universe Pharmaceuticals and Sonoma Pharmaceuticals

The main advantage of trading using opposite Universe Pharmaceuticals and Sonoma Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Universe Pharmaceuticals position performs unexpectedly, Sonoma Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonoma Pharmaceuticals will offset losses from the drop in Sonoma Pharmaceuticals' long position.
The idea behind Universe Pharmaceuticals and Sonoma Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Money Managers
Screen money managers from public funds and ETFs managed around the world